Candida auris, an emerging multidrug-resistant yeast associated with a high mortality rate, has been increasingly reported outside the United States to cause outbreaks in hospital settings ([1][1]). Although this organism is rare in the United States, its prevalence may be underestimated because of
No takes yet. Share an insight, caveat, or question.
Mizusawa et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: